Xometry (NASDAQ:XMTR) Receives Neutral Rating from The Goldman Sachs Group

Key Points

• Xometry's stock received a "neutral" rating from The Goldman Sachs Group, with a price target raised to $49.00, indicating a potential upside of 0.64% from its current price.
• The company reported a quarterly revenue of $162.55 million, surpassing estimates, with a positive earnings per share of $0.09 compared to the expected $0.05.
• Institutional investors hold 97.31% of Xometry's stock, highlighting significant investment interest in the company.

Xometry (NASDAQ:XMTR - Get Free Report)'s stock had its "neutral" rating restated by investment analysts at The Goldman Sachs Group in a research note issued on Thursday, Marketbeat reports. They presently have a $49.00 price target on the stock, up from their prior price target of $42.00. The Goldman Sachs Group's price target would indicate a potential upside of 0.64% from the company's current price.

XMTR has been the subject of several other reports. JMP Securities upped their target price on shares of Xometry from $45.00 to $50.00 and gave the company a "market outperform" rating in a research note on Wednesday, August 6th. Cantor Fitzgerald upgraded shares of Xometry from an "underweight" rating to a "neutral" rating and set a $41.00 target price for the company in a research note on Tuesday, August 5th. Citigroup reaffirmed an "outperform" rating on shares of Xometry in a report on Friday, July 11th. UBS Group upped their price target on shares of Xometry from $35.00 to $40.00 and gave the company a "neutral" rating in a report on Wednesday, August 6th. Finally, Weiss Ratings reaffirmed a "sell (e+)" rating on shares of Xometry in a report on Wednesday, October 8th. Five research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average price target of $41.22.

Xometry Price Performance

Shares of XMTR stock opened at $48.69 on Thursday. The company has a market capitalization of $2.47 billion, a PE ratio of -39.59 and a beta of 0.89. The firm has a fifty day simple moving average of $49.95 and a 200-day simple moving average of $37.18. The company has a current ratio of 3.91, a quick ratio of 3.85 and a debt-to-equity ratio of 1.20. Xometry has a twelve month low of $18.59 and a twelve month high of $58.03.

Xometry (NASDAQ:XMTR - Get Free Report) last announced its earnings results on Tuesday, August 5th. The company reported $0.09 earnings per share for the quarter, beating the consensus estimate of $0.05 by $0.04. The business had revenue of $162.55 million during the quarter, compared to the consensus estimate of $156.53 million. Xometry had a negative net margin of 10.20% and a negative return on equity of 6.79%. The business's quarterly revenue was up 22.6% compared to the same quarter last year. During the same period in the prior year, the firm earned ($0.01) earnings per share. Xometry has set its Q3 2025 guidance at EPS. Equities research analysts anticipate that Xometry will post -0.66 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Xometry news, CFO James Miln sold 598 shares of the stock in a transaction on Tuesday, September 2nd. The shares were sold at an average price of $50.25, for a total transaction of $30,049.50. Following the sale, the chief financial officer directly owned 144,115 shares of the company's stock, valued at approximately $7,241,778.75. This represents a 0.41% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Randolph Altschuler sold 9,331 shares of the stock in a transaction on Thursday, October 2nd. The stock was sold at an average price of $50.31, for a total transaction of $469,442.61. Following the sale, the chief executive officer directly owned 310,271 shares in the company, valued at $15,609,734.01. This trade represents a 2.92% decrease in their ownership of the stock. The disclosure for this sale can be found here. 9.66% of the stock is currently owned by corporate insiders.

Institutional Trading of Xometry

A number of large investors have recently modified their holdings of the company. Sheets Smith Investment Management acquired a new stake in shares of Xometry in the 3rd quarter worth about $963,000. AssuredPartners Investment Advisors LLC acquired a new stake in shares of Xometry in the 3rd quarter worth about $282,000. Osaic Holdings Inc. increased its holdings in shares of Xometry by 27.2% in the 2nd quarter. Osaic Holdings Inc. now owns 4,438 shares of the company's stock worth $150,000 after acquiring an additional 948 shares during the period. Centaurus Financial Inc. acquired a new stake in shares of Xometry in the 2nd quarter worth about $117,000. Finally, Squarepoint Ops LLC increased its holdings in shares of Xometry by 33.9% in the 2nd quarter. Squarepoint Ops LLC now owns 183,799 shares of the company's stock worth $6,211,000 after acquiring an additional 46,502 shares during the period. Institutional investors and hedge funds own 97.31% of the company's stock.

Xometry Company Profile

Xometry, Inc operates an online marketplace that enables buyers to source custom-manufactured parts and assemblies in the United States and internationally. It provides computer numerical control manufacturing, sheet metal forming, and sheet cutting; 3D printing, including fused deposition modeling, direct metal laser sintering, PolyJet, stereolithography, selective laser sintering, binder jetting, carbon digital light synthesis, multi jet fusion, and lubricant sublayer photo-curing; and die casting, stamping, injection molding, urethane casting, tube cutting, and tube bending, as well as finishing services, rapid prototyping, and high-volume production services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.